David G Adams

David G Adams

0.0
Not yet reviewed Write a Review

Licensed for 48 years

Advertising Lawyer at Washington, DC
Practice Areas: Advertising, Business, Communications & Media ... +2 more

1325 G St NW Ste 500, Washington, DC

Claim Profile

Is this your profile? Claiming it is free and only takes 2 minutes.

About David

Practice Areas

Fees and Rates

We have not found any cost information for this lawyer


Looking for an attorney? Avvo can help.

search module image

Search our directory

Quickly connect with top attorneys through our legal directory to get help with your legal issue.

chat module image

Avvo's live chat agents can help coordinate a consultation with a local attorney.

Chat with a live agent who can match you with the right attorney for your legal needs.

Chat with

Licenses

Licensed in Georgia for 48 years

State: Georgia

Acquired: 1977

Emeritus

No misconduct found

Licensed in District of Columbia for 31 years

State: District of Columbia

Acquired: 1995

Administratively Suspended - Non-Payment of Dues

No misconduct found

Location

Adams Law

1325 G St NW Ste 500, Washington, DC, 20005-3136

Law Offices of David G Adams

1325 G St NW Ste 500, Washington, DC, 20005-3136

Ad

Transform legal challenges into solutions.

Connect now to review your situation.

The Avvo Rating explained

display-bg

The Avvo Rating explained

David G Adams's Reviews

Avvo Review Score

0.0 /5.0

Not Yet Reviewed

David G Adams's Lawyer Endorsements

Endorse David

No Endorsement Data Available Yet
This attorney hasn't received any attorney endorsements recently on Avvo.

No Endorsement Data Available Yet
This attorney hasn't created any attorney endorsements recently on Avvo.

Experience

Honors

N/A

The Best Lawyers in America,

Education

N/A

New York University School of Law

Speaking Engagements

2006

Food and Drug Law Institute

Patents, Exclusivity, and Generic Drugs

2005

Medical Education Congress

Regulatory Liability Based on Support for CME

2005

Food and Drug Law Institute

NDAs, ANDAs, Patents, and Exclusivity

2005

Drug Information Association

Regulatory Liability Based on Intended Use

2004

Pharmaceutical Education Association

Product Life Cycle Management

2004

Food and Drug Law Institute

FDA Regulation of Marketing,

2004

Drug Information Association

Current Issues in Regulation of Continuing Medical Education

2004

American Conference Institute

Disseminating Product Information Prior to Approval

2003

Drug Information Association

Current Issues in FDA Regulation of Prescription Drug Promotion

2002

Food and Drug Law Institute

FDA’s First Amendment Review

2002

Federalist Society

Constitutional Limitations on FDA Regulation of Promotion

2002

Drug Information Association

FDA Regulation of Drug Marketing

2001

Drug Information Association

Pre-Approval Promotion: How to Do It Legally

2001

Drug Information Association

Current FDA Enforcement of Drug Advertising Requirements

2001

American Medical Association

Industry-Supported Information on Therapeutic Products

2000

Drug Information Association

Constitutional Challenges to FDA Implementation of FDAMA

2000

Drug Information Association

Current FDA Enforcement of Drug Advertising Requirements

2000

American Conference Institute

Federal Regulation of Drug Information on the Internet

Publications

2005

Best Practices for Food and Drug Law Essential Elements of FDA Practice and Strategy

1998

Fundamentals of Law and Regulation Supplement Key Provisions of the Food and Drug Modernization Act Relating to Drugs and Biologics

1997

Adams, ed. Fundamentals of Law and Regulation Vol. II: An In-Depth Look at Therapeutic Products

1995

Unknown USPTO and FDA Rulings Limit Uruguay Round Agreements Act Benefits and Protections for Certain Patents on FDA-Regulated Products

1995

Unknown FDA’s Final Regulations on Generic Drug Approval: Marketing Exclusivity

1994

Unknown FDA’s Final Regulations on Generic Drug Approval: Patent Protections, Patent Challenges

1994

24 Seton Hall L. Rev., 1399 FDA Regulation of Communications on Pharmaceutical Products

1993

47 Food and Drug Law Journal 624 FDA Policy on Industry-Supported Scientific and Educational Activities

1992

D. Patak Ed. Pharmaceutical Advertising: Education versus Promotion

N/A

Promotion of Pharmaceuticals Pharmaceutical Advertising: Education versus Promotion

N/A

7 J. of Pharmaceutical Marketing and Management 53 Pharmaceutical Advertising: Education versus Promotion
Avvo Rating

Our Rating is calculated using information the lawyer has included on their profile in addition to the information we collect from state bar associations and other organizations that license legal professionals. Attorneys who claim their profiles and provide Avvo with more information tend to have a higher rating than those who do not.

What determines Avvo Rating?
  • Experience & background Years licensed, work experience, education
  • Legal community recognition Peer endorsements, associations, awards
  • Legal thought leadership Publications, speaking engagements
  • Discipline Disciplinary information may not be comprehensive, or updated. We recommend that you always check a lawyer's disciplinary status with their respective state bar association before hiring them.
Avvo Rating Levels
10.0 - 9.0 Superb8.9 - 8.0 Excellent7.9 - 7.0 Very Good6.9 - 6.0 Good5.9 - 5.0 Average4.9 - 4.0 Concern3.9 - 3.0 Caution2.9 - 2.0 Strong Caution1.9 - 1.0 Extreme Caution